Category: Pharma Industry

HRSA Audit Finds Fourth Drugmaker Owes Refunds

October 13, 2023 Rich Daly, Editor in Chief Views

Drugmaker RedHill Biopharma owes repayments to 340B covered entities, a finalized HRSA audit found.

A fourth drugmaker owes repayment to 340B covered entities, according to final audits posted this week by federal officials. RedHill [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Astellas Ends 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

October 11, 2023 William Newton, Associate Editor/Senior Writer Views

Astellas is the third drugmaker to loosen or end its 340B contract pharmacy restrictions in Arkansas and Louisiana in response to state laws.

Drugmaker Astellas has ended its 340B contract pharmacy restrictions in both Arkansas and Louisiana in response to state laws that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drugmaker Overcharge Fines for 340B Drugs Reach Nearly $7,000

October 11, 2023 Rich Daly, Editor in Chief Views

Drugmaker overcharge fines, which the Department of Health and Human Services assesses, recently increased to nearly $7,000.

The federal fine for each instance of drugmaker overcharges for 340B covered entities recently increased to nearly $7,000. The fine [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Two Drugmakers Post Refund Notices on HRSA Website

October 11, 2023 Rich Daly, Editor in Chief Views

Drugmakers Noven and Granules each owe refunds to 340B providers, according to notices posted on HRSA's Office of Pharmacy Affairs website.

Noven Pharmaceuticals and Granules Pharmaceuticals owe refunds to 340B providers, according to notices posted on the Health Resources and Services [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

BMS Expands 340B Contract Pharmacy Conditions, Including for Grantees

October 6, 2023 Tom Mirga, Editor at Large Views

Bristol Myers Squibb has announced updates to its conditions on pharmaceutical sales involving contract pharmacies.

Bristol Myers Squibb (BMS) announced updates to its conditions on pharmaceutical sales involving contract pharmacies, effective Nov. 1. BMS outlined [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Novartis Offering 340B Refunds on Two Diagnostic Radiopharmaceuticals

October 5, 2023 Tom Mirga, Editor at Large Views

Drugmaker Novartis is offering refunds to 340B covered entities on certain purchases of two radiopharmaceuticals.

Drug manufacturer Novartis is offering 340B covered entities refunds on purchases of two imaging agents, partly contingent on whether an [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Major Drugmakers Agree to Negotiate Drug Prices with Medicare

October 5, 2023 William Newton, Associate Editor/Senior Writer Views

Judge Michael Newman of the U.S. District Court for the Southern District of Ohio denied a business group's request to pause Medicare negotiations while legal challenges to the IRA play out.

Medicare drug price negotiations will move ahead as planned after major drugmakers agreed to participate and a federal district judge [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Eisai Adopts 340B Contract Pharmacy Restrictions, Pfizer and GSK Update Their Limits

October 3, 2023 Tom Mirga, Editor at Large Views

Drugmaker Eisai's 340B hospital contract pharmacy restrictions will not apply to Arkansas and Louisiana providers.

Japanese pharmaceutical manufacturer Eisai will restrict 340B pricing on six drugs when dispensed by hospitals’ contract pharmacies. It is the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AbbVie Joins Legal Battle Over Louisiana’s 340B Contract Pharmacy Law

October 3, 2023 William Newton, Associate Editor/Senior Writer Views

Hospital groups urged a federal district court to dismiss drugmaker AbbVie's lawsuit against Lousiana's 340B contract pharmacy law.

Drugmaker AbbVie has sued Louisiana over its 340B contract pharmacy law, joining a series of drug industry suits that challenge [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lilly and Novo Post 340B Refund Notices, Amgen Posts 340B Replenishment Notice

September 28, 2023 Tom Mirga, Editor at Large Views

Lilly and Novo Nordisk are refunding 340B covered entities on some products due to 340B ceiling price adjustments.

Drugmakers Lilly and Novo Nordisk are giving covered entities refunds on some products due to 340B ceiling price adjustments, according [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live